Cellectis (CLLS) Cash & Current Investments (2013 - 2026)

Cellectis' Cash & Current Investments history runs 14 years deep, the most recent figure standing at $185.7 million for Q1 2026.

• On a quarterly basis, Cash & Current Investments fell 23.81% year-over-year to $185.7 million in Q1 2026; TTM through Mar 2026 was $185.7 million, a 23.81% decrease from a year earlier, with the FY2025 full-year figure at $208.7 million, down 19.84% from the prior year.
• Cash & Current Investments retreated to $185.7 million in Q1 2026 per CLLS's latest filing, from $208.7 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $345.2 million in Q4 2023 and bottomed at $67.4 million in Q3 2023.
• The 5-year median for Cash & Current Investments is $192.2 million (2025), against an average of $185.3 million.
• Across the five-year window, Cash & Current Investments sank 45.67% in 2022 and soared 287.4% in 2024, its largest moves.
• Year by year, Cash & Current Investments stood at $101.1 million in 2022, then surged by 241.35% to $345.2 million in 2023, then slipped by 24.59% to $260.3 million in 2024, then fell by 19.84% to $208.7 million in 2025, then decreased by 11.02% to $185.7 million in 2026.
• Per Business Quant, the three latest CLLS Cash & Current Investments figures stand at $185.7 million (Q1 2026), $208.7 million (Q4 2025), and $192.2 million (Q3 2025).